Filter posts

How to Survive the Patent Cliff: Eli Lilly’s CEO at the BIO CEO & Investor Conference

Like a number of companies, Eli Lilly is confronting a wave of patent expirations called …

Celgene CEO on New Multiple Myeloma Drug Approvals

Following on the heels of two big announcements in February, Celgene CEO Robert Hugin (one …

Beantown Biotech: 'Dominant Life Sciences Cluster'

Massachusetts’ Secretary of Housing and Economic Development, Greg Bialecki, was quoted in today’s Boston Herald …

Virginia Bio Announces New Executive Leadership

The Virginia Biotechnology Association (Virginia Bio), the premier statewide non-profit trade association for life science …

A Start-Up Model Worthy of Consideration

Biotech LLCs are getting a lot of attention lately, and perhaps rightfully so. The Wall …

Colorado Biotech's Big Day

Last week, the Colorado BioScience Association (CBSA) hosted its annual BioWest Conference – a one …

New Report Shows Strength of Massachusetts' Biotech Industry

If you read this blog, there’s a good chance you already know that Massachusetts is …

Award Honors Rhode Island Biotech Excellence

Know somebody in Rhode Island biotech that deserves special recognition? Then nominate them for Tech …

Managing in a Cost-Constrained Environment

By Jill E. Sackman, D.V.M., Ph.D., Senior Consultant, and Matt Levy, J.D., Business Analyst, at …

Biopharma Industry Enthusiastic About 2012

By Eric S. Langer, president and managing partner, BioPlan Associates, Inc. 2012 Annual Study shows budgets, …